These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35155681)
1. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme. Wang K; Lu Y; Liu Z; Diao M; Yang L Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma. Bi Y; Wu ZH; Cao F BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019 [TBL] [Abstract][Full Text] [Related]
3. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
4. A robust two-gene signature for glioblastoma survival prediction. Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992 [TBL] [Abstract][Full Text] [Related]
5. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
6. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma. Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434 [TBL] [Abstract][Full Text] [Related]
7. Identification of Hypoxia Prognostic Signature in Glioblastoma Multiforme Based on Bulk and Single-Cell RNA-Seq. Ahmed YB; Ababneh OE; Al-Khalili AA; Serhan A; Hatamleh Z; Ghammaz O; Alkhaldi M; Alomari S Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339384 [TBL] [Abstract][Full Text] [Related]
8. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
9. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma. Prasad B; Tian Y; Li X Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483 [TBL] [Abstract][Full Text] [Related]
10. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer. Fatai AA; Gamieldien J BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS. Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841 [TBL] [Abstract][Full Text] [Related]
12. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme. Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826 [TBL] [Abstract][Full Text] [Related]
13. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related]
14. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme. Sun G; Liu W Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685 [TBL] [Abstract][Full Text] [Related]
15. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients. Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757 [TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of an immune-based prognostic score model in glioblastoma. Qin Z; Zhang X; Chen Z; Liu N Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425 [TBL] [Abstract][Full Text] [Related]
17. A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling. Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364 [TBL] [Abstract][Full Text] [Related]
18. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma. Huang QR; Li JW; Pan XB Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227 [TBL] [Abstract][Full Text] [Related]
19. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911 [TBL] [Abstract][Full Text] [Related]
20. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development. Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D Front Immunol; 2022; 13():773264. PubMed ID: 35185876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]